Literature DB >> 2309936

Adrenergic effects on thyroxine 5'-deiodinase in brown adipose tissue of lean and ob/ob mice.

A L Kates1, G Zaror-Behrens, J Himms-Hagen.   

Abstract

Genetically obese, ob/ob, mice have an impaired capacity to increase the level of thyroxine 5'-deiodinase (T5'D) in their brown adipose tissue (BAT) when they are exposed to cold. Yet they are able to secrete norepinephrine (NE) from the nerves of their BAT in response to cold and are apparently refractory to this action of NE. The principal objective was to find out whether injected NE could increase T5'D in BAT of the ob/ob mouse. A secondary objective was to elucidate the nature of the adrenergic receptor(s) involved in this response in lean and ob/ob mice. Injection of NE increased T5'D in BAT of lean mice within 3 h. It also increased T5'D in BAT of ob/ob mice but to a lesser extent. Basal T5'D activity in BAT of ob/ob mice was greater than that seen in BAT of lean mice because of the greater size of the tissue. Neither isopropylnorepinephrine nor phenylephrine alone could increase T5'D activity, but a combination increased it almost as well as did NE, although to a lesser extent in ob/ob mice than in lean mice. Both a beta-adrenergic antagonist (propranolol) and an alpha 1-adrenergic antagonist (prazosin) could inhibit the effect of NE. The acute effect of NE on metabolic rate of intact mice also involves an action of both beta- and alpha 1-adrenergic receptors. The beta-adrenergic component appears to be defective in the ob/ob mouse.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2309936     DOI: 10.1152/ajpregu.1990.258.2.R430

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  1 in total

1.  Dexamethasone reduces energy expenditure and increases susceptibility to diet-induced obesity in mice.

Authors:  Raffaella Poggioli; Cintia B Ueta; Rafael Arrojo E Drigo; Melany Castillo; Tatiana L Fonseca; Antonio C Bianco
Journal:  Obesity (Silver Spring)       Date:  2013-09       Impact factor: 5.002

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.